BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND MAML2, MAM3, 84441, ENSG00000184384, MAM-3, MLL-MAML2, Q8IZL2, KIAA1819, DKFZp686N0150, MAM2
29 results:

  • 1. Spindle cell porocarcinoma with a novel YAP1::MAML3 fusion.
    Li P; Busam KJ
    J Cutan Pathol; 2024 Mar; 51(3):226-229. PubMed ID: 38088454
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Gene fusions in poroma, porocarcinoma and related adnexal skin tumours: An update.
    Kervarrec T; Pissaloux D; Tirode F; de la Fouchardière A; Sohier P; Frouin E; Hamard A; Houben R; Schrama D; Barlier A; Cribier B; Battistella M; Macagno N
    Histopathology; 2024 Jan; 84(2):266-278. PubMed ID: 37609771
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Sweat Gland Tumors Arising on Acral Sites: A Molecular Survey.
    Kervarrec T; Tallet A; Macagno N; de la Fouchardière A; Pissaloux D; Tirode F; Bravo IG; Nicolas A; Baulande S; Sohier P; Balme B; Osio A; Jullie ML; Moulonguet I; Bonsang B; Tournier E; Herfs M; Frouin E; Zidan A; Calonje E; Berthon P; Touzé A; Seris A; Mortier L; Jouary T; Cribier B; Battistella M
    Am J Surg Pathol; 2023 Oct; 47(10):1096-1107. PubMed ID: 37505808
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Primary mucoepidermoid carcinoma of the external auditory canal with a CRTC1::maml2 fusion: A case report and a review of literature.
    De la Sancha C; Kuhar M; Kraft A; Alomari AK
    J Cutan Pathol; 2023 Nov; 50(11):947-950. PubMed ID: 37394842
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Recurrent PAK2 rearrangements in poroma with folliculo-sebaceous differentiation.
    Kervarrec T; Pissaloux D; Paindavoine S; Tirode F; Osio A; Mourah S; Jouenne F; Sohier P; Calonje E; Pekar A; Luna EVE; Goto K; Delalande F; Frouin E; Macagno N; Drouot F; Faisan M; Cribier B; Battistella M; de la Fouchardière A
    Histopathology; 2023 Aug; 83(2):310-319. PubMed ID: 37199682
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Porocarcinoma with YAP1-NUTM1 fusion presenting as a NUT immunohistochemistry-positive lymph node metastasis.
    Christensen DJ; Tuluc M
    J Cutan Pathol; 2023 May; 50(5):410-414. PubMed ID: 36794976
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. YAP1::maml2 fusions in poromatosis: A report of two patients.
    Mitsui Y; Ogawa K; Goto K; Fujii T; Nakamura-Nishimura Y; Mashiba K; Asada H
    J Cutan Pathol; 2023 Aug; 50(8):695-701. PubMed ID: 36723803
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Distinct regulations driving YAP1 expression loss in poroma, porocarcinoma and RB1-deficient skin carcinoma.
    Kervarrec T; Frouin E; Collin C; Tallet A; Tallegas M; Pissaloux D; Tirode F; Guyétant S; Samimi M; Gaboriaud P; Touzé A; Schrama D; Houben R; Tabareau-Delalande F; Neuhart A; de la Fouchardière A; Osio A; Cavelier-Balloy B; Laurent-Roussel S; Sohier P; Cyprien T; Balme B; Belzung F; Jullie ML; Cribier B; Battistella M; Macagno N
    Histopathology; 2023 May; 82(6):885-898. PubMed ID: 36720791
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. maml2 Gene Rearrangement Occurs in Nearly All Hidradenomas: A Reappraisal in a Series of 20 Cases.
    Russell-Goldman E; Hanna J
    Am J Dermatopathol; 2022 Nov; 44(11):806-811. PubMed ID: 35925563
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Molecular analysis of NUT-positive poromas and porocarcinomas identifies novel break points of YAP1::NUTM1 fusions.
    Snow JT; Georgantzoglou N; Green DC; Parra O; LeBlanc RE; Yan S; Sriharan A; Momtahen S; Winnick KN; Dimonitsas E; Stavrianos S; Lakiotaki E; Korkolopoulou P; Revelos K; Guo R; Linos K
    J Cutan Pathol; 2022 Oct; 49(10):850-858. PubMed ID: 35665951
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Recurrent YAP1::maml2 fusions in "nodular necrotizing" variants of myxoinflammatory fibroblastic sarcoma: a comprehensive study of 7 cases.
    Perret R; Tallegas M; Velasco V; Soubeyran I; Coindre JM; Azmani R; Baud J; Bacle G; De Pinieux G; Le Loarer F
    Mod Pathol; 2022 Oct; 35(10):1398-1404. PubMed ID: 35546636
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Poroid adnexal skin tumors with YAP1 fusions exhibit similar histopathologic features: A series of six YAP1-rearranged adnexal skin tumors.
    Prieto-Granada C; Morlote D; Pavlidakey P; Rodriguez-Waitkus P; Ramirez C; Florento E; Swensen J; Gatalica Z; Stevens TM
    J Cutan Pathol; 2021 Sep; 48(9):1139-1149. PubMed ID: 33704800
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Utility of YAP1 and NUT immunohistochemistry in the diagnosis of porocarcinoma.
    Russell-Goldman E; Hornick JL; Hanna J
    J Cutan Pathol; 2021 Mar; 48(3):403-410. PubMed ID: 33222286
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Recurrent YAP1 and maml2 Gene Rearrangements in Retiform and Composite Hemangioendothelioma.
    Antonescu CR; Dickson BC; Sung YS; Zhang L; Suurmeijer AJH; Stenzinger A; Mechtersheimer G; Fletcher CDM
    Am J Surg Pathol; 2020 Dec; 44(12):1677-1684. PubMed ID: 32991341
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Are there EWSR1 rearranged cutaneous hidradenomas and mucoepidermoid carcinomas of salivary glands? A FISH study and review of the literature.
    Bozdogan O; Kadan E; Bozdogan N
    Pol J Pathol; 2020; 71(2):99-106. PubMed ID: 32729300
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. YAP1-maml2-Rearranged Poroid Squamous Cell Carcinoma (Squamoid Porocarcinoma) Presenting as a Primary Parotid Gland Tumor.
    Agaimy A; Stoehr R; Tögel L; Hartmann A; Cramer T
    Head Neck Pathol; 2021 Mar; 15(1):361-367. PubMed ID: 32504288
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Recurrent YAP1-maml2 and YAP1-NUTM1 fusions in poroma and porocarcinoma.
    Sekine S; Kiyono T; Ryo E; Ogawa R; Wakai S; Ichikawa H; Suzuki K; Arai S; Tsuta K; Ishida M; Sasajima Y; Goshima N; Yamazaki N; Mori T
    J Clin Invest; 2019 May; 129(9):3827-3832. PubMed ID: 31145701
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A novel fusion gene CRTC3-maml2 in hidradenoma: histopathological significance.
    Kuma Y; Yamada Y; Yamamoto H; Kohashi K; Ito T; Furue M; Oda Y
    Hum Pathol; 2017 Dec; 70():55-61. PubMed ID: 29079171
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Cutaneous hidradenoma: a study of 21 neoplasms revealing neither correlation between the cellular composition and CRTC1-maml2 fusions nor presence of CRTC3-maml2 fusions.
    Kyrpychova L; Kacerovska D; Vanecek T; Grossmann P; Michal M; Kerl K; Kazakov DV
    Ann Diagn Pathol; 2016 Aug; 23():8-13. PubMed ID: 27402217
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Lymph node location of a clear cell hidradenoma: report of a patient and review of literature.
    Tingaud C; Costes V; Frouin E; Delfour C; Cribier B; Guillot B; Szablewski V
    J Cutan Pathol; 2016 Aug; 43(8):702-6. PubMed ID: 27080562
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.